Peter Verdult

Stock Analyst at Citigroup

(0.42)
# 4,246
Out of 5,131 analysts
6
Total ratings
33.33%
Success rate
-13.93%
Average return

Stocks Rated by Peter Verdult

Eli Lilly and Company
Nov 12, 2025
Maintains: Buy
Price Target: $1,250$1,500
Current: $1,098.10
Upside: +36.60%
Evotec SE
Jun 8, 2023
Upgrades: Buy
Price Target: n/a
Current: $3.68
Upside: -
Galapagos NV
Jan 27, 2022
Upgrades: Buy
Price Target: n/a
Current: $33.19
Upside: -